HIV p15

HIV p15 Full Name

human immunodeficiency virus p15

HIV p15 Introduction

HIV p15 is a C-terminal segment of the HIV-1 Gag polyprotein precursor, Pr55Gag, produced through proteolytic cleavage by the viral protease during virion maturation. As one of the key Gag-derived products, p15 contributes to the nucleocapsid (NC) and spacer regions that are essential for proper viral particle assembly and maturation. Within the sequential cleavage cascade of Pr55Gag, other mature products such as p17 (matrix) and p24 (capsid) are also generated, with p15 forming a distinct segment that subsequently gives rise to smaller NC-derived fragments involved in RNA binding and genome packaging. This proteolytic processing is tightly regulated, and the formation of p15 and its derivatives is critical for generating infectious virions. By acting as a precursor to functional nucleocapsid components, p15 helps establish the structural and functional integrity of the viral core, demonstrating its central role in HIV biology.

Beyond its structural contributions, p15 has important functional properties that extend to RNA interactions and immunogenicity. The nucleocapsid-containing portion of p15 participates in RNA binding, influencing both the efficiency of viral genome encapsidation and susceptibility to protease cleavage. RNA-dependent interactions within p15-derived NC fragments have been shown to modulate protease activity, linking nucleic acid binding directly to maturation processes. These mechanistic insights highlight how p15 coordinates structural assembly with functional requirements during virion maturation. Comparative studies in related lentiviruses, such as equine infectious anemia virus (EIAV), further support the functional relevance of the p15 region. In EIAV, Gag-derived p15 and p26 contain cytotoxic T lymphocyte (CTL) epitopes recognized by infected hosts, suggesting that analogous regions in HIV-1 Gag also harbor immunogenic determinants capable of eliciting cellular immune responses. This cross-lentiviral perspective emphasizes that p15 is not only a structural element but also a region of immunological significance.

The immunogenic and structural properties of p15 make it a region of interest for vaccine design and therapeutic research. In both HIV-1 and lentiviral models, Gag-derived NC regions, including p15, are consistently identified as prominent CTL targets. Mapping studies in humans and comparative models indicate that epitopes within p15 contribute to the recognition of infected cells by CD8+ T cells and can influence viral control in specific MHC contexts. These findings underscore the rationale for incorporating p15-like Gag regions into immunogen constructs aimed at eliciting broad, Gag-specific cellular immune responses. While the discrete functions of mature p15 in isolation remain nuanced, its role as part of the NC complex, its involvement in RNA-mediated maturation, and its immunogenic potential collectively highlight p15 as a conserved and functionally important element within the HIV Gag polyprotein. Understanding p15 biology deepens insights into viral assembly, immune evasion, and the design of lentiviral vaccines and therapeutics.

Alternate Names for HIV p15

gag; Gag polyprotein; Human Immunodeficiency virus 1; Nucleocapsid protein p7; p15; p6 gag; Pr55Gag; HIV-1 Gag p15; HIV-1 p15; HIV p15; human immunodeficiency virus p15

• 1. Elalouf A. In-silico Structural Modeling of Human Immunodeficiency Virus Proteins. Biomedical Engineering and Computational Biology. 2023;14.